|
ROMO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62803104331033E-12 |
| Normal-vs-Stage2 |
9.359600E-04 |
| Normal-vs-Stage3 |
7.88170000043387E-07 |
| Normal-vs-Stage4 |
6.843300E-03 |
| Stage1-vs-Stage2 |
9.878800E-03 |
| Stage1-vs-Stage3 |
5.107000E-01 |
| Stage1-vs-Stage4 |
8.453400E-01 |
| Stage2-vs-Stage3 |
1.019410E-01 |
| Stage2-vs-Stage4 |
1.621570E-01 |
| Stage3-vs-Stage4 |
8.802000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.83900000000548E-06 |
| Normal-vs-Asian |
3.972300E-02 |
| Caucasian-vs-AfricanAmerican |
8.606400E-01 |
| Caucasian-vs-Asian |
8.721000E-01 |
| AfricanAmerican-vs-Asian |
9.559200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.5348000004245E-07 |
| Male-vs-Female |
6.310600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.75329999996254E-06 |
| Normal-vs-Extreme_Weight |
1.90847337933064E-13 |
| Normal-vs-Obese |
8.16250000035268E-07 |
| Normal-vs-Extreme_Obese |
2.339800E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.360200E-01 |
| Normal_Weight-vs-Obese |
3.538000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.739000E-01 |
| Extreme_Weight-vs-Obese |
4.009200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.691600E-01 |
| Obese-vs-Extreme_Obese |
9.229800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.573100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.49467113633273E-13 |
| Normal-vs-Age(61-80Yrs) |
1.67754699020861E-13 |
| Normal-vs-Age(81-100Yrs) |
1.921600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.292600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.112000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.790300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.383200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.329400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.421900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
4.32320000000042E-05 |
| Normal-VS-KIRP CIMP |
1.564490E-04 |
| Normal-VS-Unclassified PRCC |
4.43239999999845E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.401200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.205600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.176600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.280300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.238850E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.826600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.43050016276902E-10 |
| Normal-vs-N1 |
1.8845699999992E-05 |
| Normal-vs-N2 |
7.24590000222847E-08 |
| N0-vs-N1 |
8.811600E-01 |
| N0-vs-N2 |
5.822800E-01 |
| N1-vs-N2 |
6.649000E-01 |
|
|
